CNBC Business
Neutral 0.0
AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.
Pulse AI brief
Pulse reads the full article and explains what it means for markets. Sign in to generate a brief.
AI analysis of the article above. For information only, not financial advice.



